National Stock Number
6505-01-233-7616
National Stock Number (NSN) 6505-01-233-7616, or NIIN 012337616, (methylprednisolone acetate injec) was assigned May 1, 2008 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN replaces 1 stock number, 6505008901186.
There are 3 manufacturer part numbers associated with this NSN. One of those part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 7 suppliers. Today, 6 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, only one supplier is deemed design controlled or valid supply parts.
This part number has not been procured by the US Government in over a year. There have been 2 contracts issued for this part number, with one award given. The US Government has only awarded those contracts to one supplier. The last contract numbers awarded were: SPE2DP23V0674, SPE2DP23V0677. The total value of the awarded contracts has been US$ 930.00.
There has been a small amount of demand for this national stock number. The demand for this NSN originated from less than 5 countries. Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on May 10, 2008, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.
This NSN is assigned to Item Name Code (INC) 66536. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Information is in the Hazardous Materials Information Resource System (HMIRS). NSN 6505012337616 does not contain precious metals.
This NSN is associated to Schedule B 3004320000: medicaments containing corticosteroid hormones, their derivatives and structural analogues. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325412: pharmaceutical preparation manufacturing.
This information was last updated on May 01, 2024.